journal article·2009-07-28

A Predictive Toxicological Paradigm for the Safety Assessment of Nanomaterials

Huan Meng, Tian Xia, Saji George, Andre E. Nel

ACS Nano· Volume 3· Issue 7
Publisher page

Abstract

The rate of expansion of nanomaterials calls for the consideration of appropriate toxicological paradigms in the safety assessment of nanomaterials. We advocate a predictive toxicological paradigm for the assessment of nanomaterial hazards. The predictive toxicological approach is defined as establishing and using mechanisms and pathways of injury at a cellular and molecular level to prioritize screening for adverse biological effects and health outcomes in vivo. Specifically as it relates to nanomaterials, a predictive approach has to consider the physicochemical properties of the material that leads to molecular or cellular injury and also has to be valid in terms of disease pathogenesis in whole organisms.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Heavy Metal Exposure and Toxicity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of NanoMedicine, Department of Medicine, University of California, Los Angeles

University of California Nanotoxicology Training and Research Program

University of California Center for the Environmental Impact of Nanotechnology (UC CEIN)

California NanoSystems Institute, University of California, Los Angeles

References (42)

Show source-provided references
1. Xia T. · Annu. Rev. Public Health · 2009 · 30 · 13710.1146/annurev.publhealth.031308.100155 ↗
2. Nel A. E. · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
3. Nel A. · Science · 2006 · 311 · 62210.1126/science.1114397 ↗
4. Oberdörster G. · Environ. Health Perspect. · 2005 · 113 · 82310.1289/ehp.7339 ↗
5. Colvin V. L. · Nat. Biotechnol. · 2003 · 21 · 116610.1038/nbt875 ↗
6. Oberdörster G. · Part. Fibre Toxicol. · 2005 · 2 · 110.1186/1743-8977-2-8 ↗
7. Dreher K. L. · Toxicol. Sci. · 2004 · 77 · 310.1093/toxsci/kfh041 ↗
8. Chen Z. · Toxicol. Lett. · 2006 · 163 · 10910.1016/j.toxlet.2005.10.003 ↗
9. Xia T. · Nano Lett. · 2006 · 6 · 179410.1021/nl061025k ↗
10. Xia T. · ACS Nano · 2008 · 2 · 212110.1021/nn800511k ↗
11. Xia T. · ACS Nano · 2008 · 2 · 8510.1021/nn700256c ↗
12. Donaldson K. · Part. Fibre Toxicol. · 2009 · 6 · 1310.1186/1743-8977-6-13 ↗
13. Borm P. J. A. · Nano Today · 2008 · 3 · 5610.1016/S1748-0132(08)70016-1 ↗
14. Toxicity Testing in the 21st Century: A Vision and a Strategy. National Research Council;Natl. Acad. Press:Washington, DC, 2007, http://dels.nas.edu/dels/rptbriefs/ToxicityTestingfinal.pdf.
15. Li N. · Clin. Immunol. · 2003 · 109 · 25010.1016/j.clim.2003.08.006 ↗
16. Li N. · Free Radic. Biol. Med. · 2008 · 44 · 168910.1016/j.freeradbiomed.2008.01.028 ↗
17. Araujo J. A. · Circ. Res. · 2008 · 102 · 58910.1161/CIRCRESAHA.107.164970 ↗
18. Li N. · Environ. Health Perspect. · 2003 · 111 · 45510.1289/ehp.6000 ↗
19. 10.1289/ehp.080031910.1289/ehp.0800319 ↗
20. Gong K. · Genome Biol. · 2007 · 8 · R149.110.1186/gb-2007-8-7-r149 ↗
21. Xiao G. G. · J. Biol. Chem. · 2003 · 278 · 5078110.1074/jbc.M306423200 ↗
22. Xia T. · Environ. Health Perspect. · 2004 · 112 · 134710.1289/ehp.7167 ↗
23. Ebran B. · Rev. Pneumologie Clinique · 2000 · 56 · 361
24. Kuschner W. · J. Invest. Med. · 1995 · 43 · 371
25. Jeng H. A. · J. Environ. Sci. Health A · 2006 · 41 · 269910.1080/10934520600966177 ↗
26. Wang Z. · Environ. Health Perspect. · 2005 · 113 · 23310.1289/txg.7273 ↗
27. Poland C. A. · Nat. Nano · 2008 · 3 · 42310.1038/nnano.2008.111 ↗
28. Bhattacharya J. · Nanomedicine · 2006 · 2 · 19110.1016/j.nano.2006.07.001 ↗
29. Gomez-Mejiba S. E. · Mutat. Res., Genet. Toxicol. Environ. Mutagen. · 2009 · 674 · 6210.1016/j.mrgentox.2008.09.016 ↗
30. Linse S. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 869110.1073/pnas.0701250104 ↗
31. Collins F. S. · Science · 2008 · 319 · 90610.1126/science.1154619 ↗
32. Abraham V. C. · Trends Biotechnol. · 2004 · 22 · 1510.1016/j.tibtech.2003.10.012 ↗
33. Abraham V. C. · J. Biomol. Screening · 2008 · 13 · 52710.1177/1087057108318428 ↗
34. Flenniken M. · Curr. Top. Microbiol. Immunol. · 2009 · 327 · 71
35. Periodic Patterns, Relationships and Categories of Well-Defined Nanoscale Building Blocks, Report on a National Science Foundation Workshop, 2007, http://www.nsf.gov/crssprgm/nano/GC_Charact08_Tomalia_nsf9_29_08.pdf.
36. Sun E. Y. · Bioconjugate Chem. · 2006 · 17 · 10910.1021/bc050290e ↗
37. Schmidt, K. F.Visions for the Future of Nanotechnology,http://ospp.od.nih.gov/policy/docs/NanoFrontiersinBiomedicineReport.pdf.
38. Takagi A. · J. Toxicol. Sci. · 2008 · 33 · 10510.2131/jts.33.105 ↗
39. Pan B.-F. · J. Colloid Interface Sci. · 2005 · 284 · 110.1016/j.jcis.2004.09.073 ↗
40. AshaRani P. V. · ACS Nano · 2009 · 3 · 27910.1021/nn800596w ↗
41. Shvedova A. A. · Am. J. Physiol. Lung Cell Mol. Physiol. · 2005 · 289 · L69810.1152/ajplung.00084.2005 ↗
42. Chen Z. · Environ. Sci. Technol. · 2008 · 42 · 898510.1021/es800975u ↗